Concepedia
Statistics
Publications
43
Citations
3.9K
H-Index
25
Active since
1990
Affiliations
Rutgers Cancer Institute(Current)
Rutgers, The State University of New Jersey
Merck & Co., Inc., Rahway, NJ, USA (United States)
Memorial Sloan Kettering Cancer Center
Cornell University
Rajat Bannerji is an author at Rutgers Cancer Institute specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
1990–2024
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
Bernd Gänsbacher, Karen S. Zier, Brian Daniels et al. · The Journal of Experimental Medicine · 1990 · 624 citations · Full text
Medicine, Immunology, Oncology +15
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.
Bernd Gänsbacher, Rajat Bannerji, Brian F. Daniels et al. · PubMed · 1990 · 413 citations
Life Sciences, Immunology, Oncology +17
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort
Constantine S. Tam, John N. Allan, Tanya Siddiqi et al. · Blood · 2022 · 238 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +11
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
James R. Connor, Rajat Bannerji, Shigeru Saito et al. · The Journal of Experimental Medicine · 1993 · 208 citations · Full text
Medicine, Immunology, Oncology +17
Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
Johannes Vieweg, Felicia M. Rosenthal, Rajat Bannerji et al. · PubMed · 1994 · 181 citations · Full text
1–5 of 43